Targeting the Molecular and Immunologic Features of Leiomyosarcoma

SIMPLE SUMMARY: Immunotherapy has revolutionized cancer care across different cancer types. Unfortunately, leiomyosarcoma does not seem sensitive to the first-generation immune-based therapies. In this review, we present the results of trials of immunotherapy in leiomyosarcoma, emphasizing differenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cope, Brandon M., Traweek, Raymond S., Lazcano, Rossana, Keung, Emily Z., Lazar, Alexander J., Roland, Christina L., Nassif, Elise F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093078/
https://www.ncbi.nlm.nih.gov/pubmed/37046760
http://dx.doi.org/10.3390/cancers15072099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093078/
https://www.ncbi.nlm.nih.gov/pubmed/37046760
http://dx.doi.org/10.3390/cancers15072099

Ejemplares similares